Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI)went up by 4.85% from its latest closing price when compared to the 1-year high value of $21.80 and move down -134.41%, while SPPI stocks collected +28.28% of gains with the last five trading sessions. Press Release reported on 09/06/19 that Spectrum Announces Poziotinib Data Being Presented at the IASLC 2019 World Conference on Lung Cancer
Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) Worth an Investment?
Spectrum Pharmaceuticals, Inc. (NASDAQ: SPPI) The 36 Months beta value for SPPI stocks is at 2.54, while of the analysts out of 0 who provided ratings for Spectrum Pharmaceuticals, Inc. stocks as a “buy” while as overweight, rated it as hold and as sell. The average price we get from analysts is $23.20 which is $13.9 above current price. SPPI currently has a short float of 8.23% and public float of 97.48M with average trading volume of 733.22K shares.
SPPI Market Performance
SPPI stocks went up by 28.28% for the week, with the monthly jump of 22.21% and a quarterly performance of 24.00%, while its annual performance rate touched -54.74%. The simple moving average for the period of the last 20 days is 19.91% for SPPI stocks with the simple moving average of -2.41% for the last 200 days.
Analysts’ Opinion on Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI)
Many brokerage firms have already submitted their reports for SPPI stocks, with B. Riley FBR repeating the rating for SPPI shares by setting it to “Buy”. The predicted price for SPPI socks in the upcoming period according to B. Riley FBR is $18 based on the research report published on July 11, 2019.
Jefferies, on the other hand, stated in their research note that they expect to see SPPI stock at the price of $21. The rating they have provided for SPPI stocks is “Buy” according to the report published on March 15, 2019.
B. Riley FBR gave “Buy” rating to SPPI stocks, setting the target price at $29 in the report published on November 12, 2018.
SPPI Stocks 18.95% Far from 50 Day Moving Average
After a stumble in the market that brought SPPI to its low price for the period of the last 52 weeks, Spectrum Pharmaceuticals, Inc. was unable to take a rebound, for now settling with -57.34% of loss for the given period.
The stock volatility was left at 5.78%, however, within the period of a single month, the volatility rate increased by 7.69%, while the shares surge at the distance of +17.28% for the moving average in the last 20 days. In oppose to the moving average for the last 50 days, trading by +8.64% upper at the present time.
In the course of the last 5 trading sessions, SPPI went up by +28.28%, which changed the moving average for the period of 200 days to the total of -28.57% of losses for the stock in comparison to the 20-day moving average settled at $7.82. In addition, Spectrum Pharmaceuticals, Inc. saw 6.29% in overturn over the period of a single year with a tendency to cut further gains.
SPPI Stock Insider Trading
Reports are indicating that there were more than several insider trading activities at Spectrum Pharmaceuticals, Inc. (SPPI), starting from McGahan Keith M, who sold 294 shares at the price of $7.77 back on Aug 12. After this action, Rushing now owns 135,543 shares of Spectrum Pharmaceuticals, Inc., valued at $2,283 with the latest closing price.
Ashton William, the Director of Spectrum Pharmaceuticals, Inc., sold 1,667 shares at the value of $8.50 during a trade that took place back on Jun 20, which means that Ashton William is holding 6,666 shares at the value of $14,170 based on the most recent closing price.
SPPI Stock Fundamentals
The current profitability levels are settled at -119.98 for the present operating margin and +49.83 for gross margin. The net margin for Spectrum Pharmaceuticals, Inc. stands at -109.77. Total capital return value is set at -38.99, while invested capital returns managed to touch -37.82. Equity return holds the value -60.30%, with -44.80% for asset returns.
The receivables turnover for Spectrum Pharmaceuticals, Inc. is 3.22 with the total asset turnover at the value of 0.25. The liquidity ratio also appears to be rather interesting for investors as it stands at 2.90.